name | 叶卫兵 |
sex | male
|
age | 59 岁 |
hospital number | 433630 |
height | 174 cm |
weight | 75 kg |
BSA | 1.9 m2 |
APACHEⅡ | 20 分 |
Infection source | lung
|
date | 2017/8/24 年/月/日 |
Sequential Organ Failure Assessment | 15 分 |
Fluid resuscitation | CVP8-12 mmHg
/MAP≥65 mmHg
/ScvO2≥70%
/urine volume≥0.5
|
age>=60 | no
|
septic shock | yes
|
mechanical ventilation | trachea cannula
|
Early fluid resuscitation | yes
|
age<60 | yes
|
Pregnant woman | no
|
advanced malignant tumor | no
|
Pulmonary interstitial fibrosis | no
|
Serious arrhythmia | no
|
Small Tidal Volume Ventilation | no
|
Liver failure | no
|
Refuse to participate | no
|
Heart disease | no
|
no
|
|
no
|
|
no
|
|
no
|
|
no
|
- vital signs
- Blood Gas Analysis
- vasoactive agent and fluid
- PiCCO parameters
- Cardiac Ultrasound
- lung ultrasound
- inferior vena cava
yes
|
|
斯沃+美罗培南 |
|
vasoactive agent | norepinephrine
|
120 min |
|
min |
|
720 min |
Temperature | 38.5 ℃ |
Heart Rate | 128 次/分 |
Breath | 18 次/分 |
Systolic pressure (SP) | 180 mmHg |
Diastolic pressure | 98 mmHg |
mean arterial pressure | 127 mmHg |
Pcv-aCO2 | 15.7 mmHg |
DO2 | 1044.0 |
VO2 | 169.1 |
Ca-vO2 | 21.8 |
pH value | 7.29 |
PaO2 | 76.2 mmHg |
PaCO2 | 28.2 mmHg |
BE | -11.8 mmol/L(±2.3mmol/L) |
SaO2 | 96.5 % |
Blood lactic acid concentration, LAC | 8 mmol/L |
Oxygenation index (PaO2/FiO2) | 127 mmHg |
pH value | 7.24 |
PcvO2 | 48.1 mmHg |
PcvCO2 | 43.9 mmHg |
BE | -8.1 mmol/L |
ScvO2 | 80.9 % |
Volume of input | 0 ml |
Volume of output | 0 ml |
Volume of urine | 0 ml |
ultrafiltration volume | 0 ml |
norepinephrine | yes
|
Norepinephrine Dosage | 0.07 μg/Kg/min |
dopamine | no
|
Dopamine Dosage | μg/Kg/min |
Dobutamine | No
|
Dobutamine Dosage | μg/Kg/min |
CVP | 14 mmHg |
cardiac output | 7.75 L/min |
cardiac index | 4.08 L/min/m2 |
stroke volume | 60.5 ml |
Stroke Index | 3.19 ml/m2 |
ITBVI | 1035 ml/m2 |
GEDVI | 808 ml/m2 |
EVLWI | 8.2 ml/kg |
PVPI | 1.4 |
SVRI | 2215 DSm2/cm5 |
CFI | 5.1 |
GEF | 16 % |
SVV | 9 % |
PPV | % |
dPmax | 1888 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
the number of B line | 8 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 1.8 mm |
IVC(expiratory phase) | 2.1 mm |
respiratory variations of inferior vena cavae diameter | 15 % |
1.7 mm |
|
mm |
|
2.0 mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 38 ℃ |
Heart Rate | 90 次/分 |
Breath | 18 次/分 |
Systolic Pressure | 145 mmHg |
Diastolic Pressure | 84 mmHg |
Mean Arterial Pressure | 107 mmHg |
Pcv-aCO2 | 5.8 mmHg |
DO2 | 701.8 |
VO2 | 135.9 |
Ca-vO2 | 22.7 |
PH value | 7.39 |
PaO2 | 140.2 mmHg |
PaCO2 | 30.6 mmHg |
BE | -4.7 mmol/L |
SaO2 | 99 % |
Blood Lactic Acid Concentration | 2.4 mmol/L |
Oxygenation index (PaO2/FiO2) | 233.7 mmHg |
PH value | 7.37 |
PcvO2 | 47.3 mmHg |
PcvCO2 | 36.4 mmHg |
BE | -4.2 mmol/L |
ScvO2 | 80.2 % |
Volume of input | 1.34 ml |
Volume of output | 310 ml |
Volume of urine | 310 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 8 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 15 mmHg |
cardiac output | 5.99 L/min |
cardiac index | 3.15 L/min/m2 |
stroke volume | 66.6 ml |
Stroke Index | 35 ml/m2 |
ITBVI | 930 ml/m2 |
GEDVI | 744 ml/m2 |
EVLWI | 6.3 ml/kg |
PVPI | 1.3 |
SVRI | 2333 DSm2/cm5 |
CFI | 4.3 |
GEF | 20 % |
SVV | 8 % |
PPV | / % |
dPmax | 13.2 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 4 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 1.8 mm |
IVC(expiratory phase) | 2.2 mm |
Respiratory variations of inferior vena cavae diameter | 20 % |
1.7 mm |
|
mm |
|
2.1 mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 37.6 ℃ |
Heart Rate | 79 次/分 |
Breath | 18 次/分 |
Systolic Pressure | 116 mmHg |
Diastolic Pressure | 72 mmHg |
Mean Arterial Pressure | 89 mmHg |
Pcv-aCO2 | 10.6 mmHg |
DO2 | 451.8 |
VO2 | 9.17 |
Ca-vO2 | 2.09 |
PH value | 7.45 |
PaO2 | 69.1 mmHg |
PaCO2 | 34.3 mmHg |
BE | -0.6 mmol/L |
SaO2 | 87.5 % |
Blood Lactic Acid Concentration | 2 mmol/L |
Oxygenation index (PaO2/FiO2) | 125.6 mmHg |
PH value | 7.45 |
PcvO2 | 37.7 mmHg |
PcvCO2 | 44.9 mmHg |
BE | 6.1 mmol/L |
ScvO2 | 85.8 % |
Volume of input | 2100 ml |
Volume of output | 600 ml |
Volume of urine | 600 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 18 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 15 mmHg |
cardiac output | 4.73 L/min |
cardiac index | 2.49 L/min/m2 |
stroke volume | 59.9 ml |
Stroke Index | 2.49 ml/m2 |
ITBVI | 843 ml/m2 |
GEDVI | 674 ml/m2 |
EVLWI | 5.7 ml/kg |
PVPI | 1.3 |
SVRI | 2377 DSm2/cm5 |
CFI | 3.8 |
GEF | 20 % |
SVV | 7 % |
PPV | / % |
dPmax | 687 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 4 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 1.6 mm |
IVC(expiratory phase) | 2.0 mm |
Respiratory variations of inferior vena cavae diameter | 22 % |
1.5 mm |
|
mm |
|
2.0 mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 38.3 ℃ |
Heart Rate | 76 次/分 |
Breath | 18 次/分 |
Systolic Pressure | 152 mmHg |
Diastolic Pressure | 92 mmHg |
Mean Arterial Pressure | 115 mmHg |
Pcv-aCO2 | 9.4 mmHg |
DO2 | 447.0 |
VO2 | 52.8 |
Ca-vO2 | 12.0 |
PH value | 7.44 |
PaO2 | 76.9 mmHg |
PaCO2 | 35.5 mmHg |
BE | -0.3 mmol/L |
SaO2 | 97.2 % |
Blood Lactic Acid Concentration | 2 mmol/L |
Oxygenation index (PaO2/FiO2) | 170.8 mmHg |
PH value | 7.44 |
PcvO2 | 37.7 mmHg |
PcvCO2 | 44.9 mmHg |
BE | 6.1 mmol/L |
ScvO2 | 85.8 % |
Volume of input | 4136 ml |
Volume of output | 1250 ml |
Volume of urine | 1250 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 32 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 15 mmHg |
cardiac output | 4.39 L/min |
cardiac index | 2.31 L/min/m2 |
stroke volume | 57.8 ml |
Stroke Index | 2.31 ml/m2 |
ITBVI | 846 ml/m2 |
GEDVI | 677 ml/m2 |
EVLWI | 6.0 ml/kg |
PVPI | 1.3 |
SVRI | 3461 DSm2/cm5 |
CFI | 3.5 |
GEF | 19 % |
SVV | 3 % |
PPV | / % |
dPmax | 793 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 4 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 1.8 mm |
IVC(expiratory phase) | 2.0 mm |
Respiratory variations of inferior vena cavae diameter | 10 % |
1.8 mm |
|
mm |
|
2.0 mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 19 ℃ |
Heart Rate | 79 次/分 |
Breath | 18 次/分 |
Systolic Pressure | 162 mmHg |
Diastolic Pressure | 93 mmHg |
Mean Arterial Pressure | 118 mmHg |
Pcv-aCO2 | 8.1 mmHg |
DO2 | 714.6 |
VO2 | 134.8 |
Ca-vO2 | 19.9 |
PH value | 7.42 |
PaO2 | 86.7 mmHg |
PaCO2 | 37.2 mmHg |
BE | -0.2 mmol/L |
SaO2 | 97.3 % |
Blood Lactic Acid Concentration | 3.4 mmol/L |
Oxygenation index (PaO2/FiO2) | 192.7 mmHg |
PH value | 7.41 |
PcvO2 | 50.3 mmHg |
PcvCO2 | 45.3 mmHg |
BE | 2.0 mmol/L |
ScvO2 | 79 % |
Volume of input | 7840 ml |
Volume of output | 315 ml |
Volume of urine | 315 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 48 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 14 mmHg |
cardiac output | 6.95 L/min |
cardiac index | 3.66 L/min/m2 |
stroke volume | 88 ml |
Stroke Index | 46.3 ml/m2 |
ITBVI | 990 ml/m2 |
GEDVI | 792 ml/m2 |
EVLWI | 5.2 ml/kg |
PVPI | 1.0 |
SVRI | 2273 DSm2/cm5 |
CFI | 48 |
GEF | 25 % |
SVV | 6 % |
PPV | / % |
dPmax | 599 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 4 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 1.7 mm |
IVC(expiratory phase) | 2.3 mm |
Respiratory variations of inferior vena cavae diameter | 30 % |
1.8 mm |
|
mm |
|
2.4 mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 37.8 ℃ |
Heart Rate | 77 次/分 |
Breath | 18 次/分 |
Systolic Pressure | 144 mmHg |
Diastolic Pressure | 85 mmHg |
Mean Arterial Pressure | 105 mmHg |
Pcv-aCO2 | 9.5 mmHg |
DO2 | 628.3 |
VO2 | 204.6 |
Ca-vO2 | 32.1 |
PH value | 7.43 |
PaO2 | 97 mmHg |
PaCO2 | 38.4 mmHg |
BE | 1 mmol/L |
SaO2 | 97.1 % |
Blood Lactic Acid Concentration | 3.4 mmol/L |
Oxygenation index (PaO2/FiO2) | 215.6 mmHg |
PH value | 7.38 |
PcvO2 | 28.8 mmHg |
PcvCO2 | 47.5 mmHg |
BE | 3 mmol/L |
ScvO2 | 66 % |
Volume of input | 11312 ml |
Volume of output | 5850 ml |
Volume of urine | 5850 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 82 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 10 mmHg |
cardiac output | 6.38 L/min |
cardiac index | 3.36 L/min/m2 |
stroke volume | 82.9 ml |
Stroke Index | 43.6 ml/m2 |
ITBVI | 95.7 ml/m2 |
GEDVI | 766 ml/m2 |
EVLWI | 5.5 ml/kg |
PVPI | 1.1 |
SVRI | 2286 DSm2/cm5 |
CFI | 4.5 |
GEF | 25 % |
SVV | 5 % |
PPV | / % |
dPmax | 510 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 4 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(expiratory phase) | 1.8 mm |
Respiratory variations of inferior vena cavae diameter | 2.0 % |
IVC(inspiratory phase) | 22 mm |
1.7 mm |
|
mm |
|
2.0 mm |
|
mm |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | 1663 pg/ml |
cTNI | ng/ml |
Creatine kinase isoenzyme, CKMB | U/L |
Creatinine | 173 umol/L |
Urea nitrogen | 8.7 mmol/l |
MDRD | ml/min/1.73m2 |
Date of examination | yyyy-mm-dd |
WBC | 15.2 X10*9/L |
neutrophilic granulocyte percentage | 95.9 % |
Hb | 104 g/L |
CRP | 341.22 mg/L |
Procalcitonin, PCT | 大于100 ng/ml |
Date of test | 2017/8/24 |
Sequential Organ Failure Assessment | 15 分 |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | 791 pg/ml |
cTNI | ng/ml |
Creatine kinase isoenzyme, CKMB | U/L |
Creatinine | 100 umol/L |
Urea nitrogen | 5.7 mmol/l |
MDRD | ml/min/1.73m2 |
WBC | 10.2 X10*9/L |
neutrophilic granulocyte percentage | 95.3 % |
Hb | 88 g/L |
CRP | 338.42 mg/L |
Procalcitonin, PCT | 67.85 ng/ml |
Sequential Organ Failure Assessment | 13 分 |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | 1892 pg/ml |
cTNI | ng/ml |
Creatine kinase isoenzyme, CKMB | U/L |
Creatinine | 100 umol/L |
Urea nitrogen | 6.4 mmol/L |
MDRD | ml/min/1.73m2 |
WBC | 12.7 X10*9/L |
neutrophilic granulocyte percentage | 96.5 % |
Hb | 81 g/L |
CRP | 305.37 mg/L |
Procalcitonin, PCT | 61.41 ng/ml |
Sequential Organ Failure Assessment | 12 分 |
Transfusion of Red Cells | no
|
Transfusion of Red Cells | U |
Plasma infusion | no
|
Plasma infusion | ml |
platelet transfusion | no
|
platelet transfusion | U |
APACHEⅡ | 18 分 |
Complication |
prognosis | discharge
|
28-day mortality | |
survival time(day) | 天 |
death time | yyyy/mm/dd |
diagnosis of death |
|
length of stay | 18 天 |
duration in ICU | 12 天 |
duration of mechanical ventilation | 288 小时 |
ICU expenses | 133738 元 |
Continuous Renal Replacement Therapy | no
|
Continuous Renal Replacement Therapy | 小时 |